David Rolfe - Wedgewood Partners
Holding/activity history for  Celgene Corp. (CELG)
Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
2019   Q4 | 0 | 0 | Sell 100.00% | 3.47 | |
2019   Q3 | 393,967 | 3.47 | Reduce 9.07% | 0.35 | $99.30 |
2019   Q2 | 433,260 | 3.39 | Reduce 17.50% | 0.72 | $92.44 |
2019   Q1 | 525,139 | 3.62 | Reduce 19.78% | 0.89 | $94.34 |
2018   Q4 | 654,632 | 2.78 | Reduce 13.57% | 0.44 | $64.09 |
2018   Q3 | 757,374 | 3.40 | Reduce 12.36% | 0.48 | $89.49 |
2018   Q2 | 864,236 | 3.47 | Reduce 6.52% | 0.24 | $79.42 |
2018   Q1 | 924,542 | 3.79 | Reduce 3.93% | 0.15 | $89.21 |
2017   Q4 | 962,318 | 4.06 | Add 42.19% | 1.20 | $104.36 |
2017   Q3 | 676,776 | 3.37 | Reduce 15.34% | 0.61 | $145.82 |
2017   Q2 | 799,402 | 3.18 | Add 316.36% | 2.42 | $129.87 |
2017   Q1 | 192,000 | 0.62 | Buy | 0.62 | $124.43 |